133 related articles for article (PubMed ID: 10479144)
1. Role of peroxynitrite as a mediator of pathophysiological alterations in experimental pneumococcal meningitis.
Kastenbauer S; Koedel U; Pfister HW
J Infect Dis; 1999 Oct; 180(4):1164-70. PubMed ID: 10479144
[TBL] [Abstract][Full Text] [Related]
2. Blocking of leukocyte accumulation in the cerebrospinal fluid augments bacteremia and increases lethality in experimental pneumococcal meningitis.
Brandt CT; Lundgren JD; Frimodt-Møller N; Christensen T; Benfield T; Espersen F; Hougaard DM; Ostergaard C
J Neuroimmunol; 2005 Sep; 166(1-2):126-31. PubMed ID: 15982752
[TBL] [Abstract][Full Text] [Related]
3. Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis.
Koedel U; Bernatowicz A; Frei K; Fontana A; Pfister HW
J Immunol; 1996 Dec; 157(11):5185-91. PubMed ID: 8943431
[TBL] [Abstract][Full Text] [Related]
4. Impact of bacteremia on the pathogenesis of experimental pneumococcal meningitis.
Brandt CT; Holm D; Liptrot M; Ostergaard C; Lundgren JD; Frimodt-Møller N; Skovsted IC; Rowland IJ
J Infect Dis; 2008 Jan; 197(2):235-44. PubMed ID: 18173365
[TBL] [Abstract][Full Text] [Related]
5. Induced hypothermia in experimental pneumococcal meningitis.
Angstwurm K; Reuss S; Freyer D; Arnold G; Dirnagl U; Schumann RR; Weber JR
J Cereb Blood Flow Metab; 2000 May; 20(5):834-8. PubMed ID: 10826534
[TBL] [Abstract][Full Text] [Related]
6. Heparin inhibits leukocyte rolling in pial vessels and attenuates inflammatory changes in a rat model of experimental bacterial meningitis.
Weber JR; Angstwurm K; Rosenkranz T; Lindauer U; Freyer D; Bürger W; Busch C; Einhäupl KM; Dirnagl U
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1221-9. PubMed ID: 9390654
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine kinase inhibition reduces inflammation in the acute stage of experimental pneumococcal meningitis.
Angstwurm K; Hanisch UK; Gassemi T; Bille MB; Prinz M; Dirnagl U; Kettenmann H; Weber JR
Infect Immun; 2004 Jun; 72(6):3294-8. PubMed ID: 15155632
[TBL] [Abstract][Full Text] [Related]
8. A kinetic study of the cytokine/chemokines levels and disruption of blood-brain barrier in infant rats after pneumococcal meningitis.
Barichello T; Pereira JS; Savi GD; Generoso JS; Cipriano AL; Silvestre C; Petronilho F; Dal-Pizzol F; Vilela MC; Teixeira AL
J Neuroimmunol; 2011 Apr; 233(1-2):12-7. PubMed ID: 21109308
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic interference with NF-kappaB activation attenuates central nervous system complications in experimental Pneumococcal meningitis.
Koedel U; Bayerlein I; Paul R; Sporer B; Pfister HW
J Infect Dis; 2000 Nov; 182(5):1437-45. PubMed ID: 11023466
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of tyrosine phosphatase SHP2 in experimental pneumococcal meningitis: correlation with tumor necrosis factor-alpha and cerebrospinal fluid pleocytosis.
Feng M; Sun R; Zhang C; Sun E; Wei S; Wan J; Sun R
J Child Neurol; 2008 Mar; 23(3):287-92. PubMed ID: 18305318
[TBL] [Abstract][Full Text] [Related]
11. Reactive nitrogen species contribute to blood-labyrinth barrier disruption in suppurative labyrinthitis complicating experimental pneumococcal meningitis in the rat.
Kastenbauer S; Klein M; Koedel U; Pfister HW
Brain Res; 2001 Jun; 904(2):208-17. PubMed ID: 11406118
[TBL] [Abstract][Full Text] [Related]
12. Urokinase-type plasminogen activator receptor regulates leukocyte recruitment during experimental pneumococcal meningitis.
Paul R; Winkler F; Bayerlein I; Popp B; Pfister HW; Koedel U
J Infect Dis; 2005 Mar; 191(5):776-82. PubMed ID: 15688295
[TBL] [Abstract][Full Text] [Related]
13. Differences in survival, brain damage, and cerebrospinal fluid cytokine kinetics due to meningitis caused by 3 different Streptococcus pneumoniae serotypes: evaluation in humans and in 2 experimental models.
Østergaard C; Brandt C; Konradsen HB; Samuelsson S
J Infect Dis; 2004 Oct; 190(7):1212-20. PubMed ID: 15346330
[TBL] [Abstract][Full Text] [Related]
14. Effects of Toll-like receptor 2 agonist Pam(3)CysSK(4) on inflammation and brain damage in experimental pneumococcal meningitis.
Sellner J; Grandgirard D; Gianinazzi C; Landmann RM; Leib SL
J Neuroimmunol; 2009 Jan; 206(1-2):28-31. PubMed ID: 19012971
[TBL] [Abstract][Full Text] [Related]
15. Methylprednisolone attenuates inflammation, increase of brain water content and intracranial pressure, but does not influence cerebral blood flow changes in experimental pneumococcal meningitis.
Koedel U; Pfister HW; Tomasz A
Brain Res; 1994 Apr; 644(1):25-31. PubMed ID: 8032946
[TBL] [Abstract][Full Text] [Related]
16. Experimental studies of pneumococcal meningitis.
Brandt CT
Dan Med Bull; 2010 Jan; 57(1):B4119. PubMed ID: 20175949
[TBL] [Abstract][Full Text] [Related]
17. Routes, dynamics, and correlates of cochlear inflammation in terminal and recovering experimental meningitis.
Cayé-Thomasen P; Worsøe L; Brandt CT; Miyazaki H; Ostergaard C; Frimodt-Møller N; Thomsen J
Laryngoscope; 2009 Aug; 119(8):1560-70. PubMed ID: 19504554
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of nitric oxide synthases in bacterial meningitis: role of the inducible isoform for blood-brain barrier breakdown.
Winkler F; Koedel U; Kastenbauer S; Pfister HW
J Infect Dis; 2001 Jun; 183(12):1749-59. PubMed ID: 11372027
[TBL] [Abstract][Full Text] [Related]
19. Effect of the bradykinin B2 receptor antagonist Hoe140 in experimental pneumococcal meningitis in the rat.
Lorenzl S; Ködel U; Frei K; Pfister HW
Eur J Pharmacol; 1996 Jul; 308(3):335-41. PubMed ID: 8858309
[TBL] [Abstract][Full Text] [Related]
20. S100B in the cerebrospinal fluid--a marker for glial damage in the rabbit model of pneumococcal meningitis.
Schmidt H; Gerber J; Stuertz K; Djukic M; Bunkowski S; Fischer FR; Otto M; Nau R
Neurosci Lett; 2010 May; 475(2):104-7. PubMed ID: 20347934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
